Clinical Trial

The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar-13 in young and elderly adults.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-31 -> 2027-05-31 2026-04-04
minor Completion pushed: 2026-05-31 -> 2027-05-31 2026-04-04
Trial Details
NCT Number NCT06128915
Lead Sponsor State University of New York at Buffalo
Collaborators: National Institute on Aging (NIA)
Conditions Aging
Enrollment 60 participants
Start Date 2024-01-08
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-03